Syncom Formulations Q2 Results FY27: Operating Profit Jumps 73.53%, Revenue Rs 142.14 Cr, PAT Rs 26.65 Cr
- November 13, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Syncom Formulations Q2 Results FY27 were declared on 13 November 2026 on a Consolidated basis. Revenue rose 16.78% to Rs 142.14 Cr, a firm case of YoY growth. Net profit rose 60.54% to Rs 26.65 Cr from Rs 16.60 Cr a year earlier. These quarterly results also show Operating Profit of Rs 31.93 Cr, up 73.53%.
Syncom Formulations (India) Ltd (SYNCOMF) Q2 Results FY27 announced on 13 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 142.14 Cr and PAT of Rs 26.65 Cr. Investors following Syncom Formulations Q2 Results FY27 will see profit growing faster than revenue.
This look at Syncom Formulations Q2 Results covers the financial highlights, business drivers, outlook and risks. The results analysis starts with the Financial Highlights table below, which sets each figure against the same quarter last year. Each section hands over to the next, so the figures read as one connected story.
Click Here – Get Free Investment Predictions
Syncom Formulations Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 142.14 Cr | Rs 121.72 Cr | +16.78% YoY |
| Operating Profit | Rs 31.93 Cr | Rs 18.4 Cr | +73.53% YoY |
| Net Profit (PAT) | Rs 26.65 Cr | Rs 16.6 Cr | +60.54% YoY |
Source: company filing for Syncom Formulations Q2 Results FY27, 13 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Syncom Formulations Q2 Results: What Stands Out
- Revenue rose 16.78% to Rs 142.14 Cr, against Rs 121.72 Cr in the year-ago quarter, which is solid YoY growth.
- Net profit rose 60.54% to Rs 26.65 Cr from Rs 16.60 Cr, so profit after tax outpaced revenue in Syncom Formulations Q2 Results FY27.
- Operating Profit climbed 73.53% to Rs 31.93 Cr from Rs 18.40 Cr in the same quarter last year.
- Net profit margin improved to 18.7% from 13.6% in the comparison quarter, with revenue higher as well.
- Return on equity was 20.19% in FY26, and the performance analysis below places it beside these figures.
Syncom Formulations Q2 Results FY27: Performance Analysis
The numbers in Syncom Formulations Q2 Results FY27 show revenue of Rs 142.14 Cr, up 16.78%, and Operating Profit of Rs 31.93 Cr, up 73.53%, while net profit rose to Rs 26.65 Cr. All three lines moved up, with the profit lines moving fastest, so the quarter stands out for the pace of profit growth rather than the pace of revenue growth.
Revenue grew from Rs 121.72 Cr to Rs 142.14 Cr, and in Syncom Formulations Q2 Results FY27 net profit grew from Rs 16.60 Cr to Rs 26.65 Cr. The supplied data confirms these movements but does not establish the specific cause behind them.
Operating Profit rose from Rs 18.40 Cr to Rs 31.93 Cr, a larger gain than the revenue increase. For Syncom Formulations Q2 Results, the Univest Screener lets readers follow later quarterly results against this base, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue growth – The results analysis points first to revenue, which grew 16.8% year on year to Rs 142.14 Cr in the latest quarter, the top-line movement that sits behind Syncom Formulations Q2 Results FY27.
Net profit growth – Net profit rose 60.5% year on year to Rs 26.65 Cr. This disclosed factor shows the bottom line growing well ahead of revenue in these quarterly results.
Margin and returns – Net profit margin improved to 18.7% from 13.6% in the comparison quarter, and return on equity was 20.19% in FY26. Both disclosed figures frame how much of revenue reached profit.
FY27 Outlook After Syncom Formulations Q2 Results
FY27 full-year results will depend on the subsequent quarters and on disclosed sector conditions. Since the results date of 13 November 2026, the results analysis here rests only on what the filing shows, namely revenue of Rs 142.14 Cr, Operating Profit of Rs 31.93 Cr and consolidated net profit of Rs 26.65 Cr for the July to September 2026 quarter.
Net profit is the line to follow, since Syncom Formulations Q2 Results FY27 puts it at Rs 26.65 Cr against Rs 16.60 Cr a year earlier. Each new filing will add to that record, and the points to watch alongside it are covered next.
Key Risks to Watch After Syncom Formulations Q2 Results FY27
Higher Profit Base
Net profit grew 60.54% and Operating Profit grew 73.53% in Syncom Formulations Q2 Results FY27. Later quarters will be compared against these higher figures, which is simple arithmetic on the supplied numbers.
Margin Base of 18.7%
Net profit margin improved to 18.7% from 13.6% in the comparison quarter. Future quarterly results will be measured against that margin, next to the 16.78% YoY growth in revenue.
Profit Growth Ahead of Revenue
Net profit growth of 60.54% and Operating Profit growth of 73.53% both sit well ahead of revenue growth of 16.78%. That gap is worth tracking quarter by quarter in later filings.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Syncom Formulations Q2 Results FY27 show revenue of Rs 142.14 Cr, Operating Profit of Rs 31.93 Cr and net profit of Rs 26.65 Cr on a Consolidated basis. From the results date onward, these quarterly results leave investors with higher revenue and sharply higher net profit to weigh. For Syncom Formulations Q2 Results, the consolidated results are best read in full on the Univest app. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Syncom Formulations Q2 Results FY27
What are Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations Q2 Results FY27 were declared on 13 November 2026 with revenue of Rs 142.14 Cr and net profit of Rs 26.65 Cr, while the Financial Highlights table above lays out every figure and YoY growth.
What is the results date for Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations declared its Q2 FY27 results on 13 November 2026, so the results date covers July to September 2026, as the introduction of this article explains.
What revenue was reported in Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations reported Q2 FY27 revenue of Rs 142.14 Cr, compared with Rs 121.72 Cr a year earlier, as the Financial Highlights table above shows.
What net profit was reported in Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations reported Q2 FY27 net profit of Rs 26.65 Cr, which means a 60.54% rise from Rs 16.60 Cr in the same quarter last year, per the Key Takeaways.
How much YoY growth did revenue show in Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations Q2 Results FY27 show revenue up 16.78% year on year, and alongside this, Operating Profit rose 73.53% to Rs 31.93 Cr, as the Performance Analysis explains.
Did net profit rise or fall in Syncom Formulations Q2 Results?
Ans. Syncom Formulations Q2 Results show net profit rising 60.54% to Rs 26.65 Cr, compared with Rs 16.60 Cr a year ago, so the Key Takeaways list it as a gain well ahead of revenue.
What was the Operating Profit in Syncom Formulations Q2 Results FY27?
Ans. Syncom Formulations posted Operating Profit of Rs 31.93 Cr in Q2 FY27, against Rs 18.40 Cr a year earlier, which means a 73.53% rise, per the results analysis in the Performance Analysis.
Are Syncom Formulations Q2 Results consolidated results or standalone results?
Ans. Syncom Formulations Q2 Results are consolidated results, which means they cover the company on a Consolidated basis as supplied, and the Quick Answer box at the top of the article states this basis.
What business factors shaped Syncom Formulations Q2 Results FY27?
Ans. The disclosed factors for Syncom Formulations Q2 Results FY27 are 16.8% revenue growth, 60.5% net profit growth and a net profit margin of 18.7%, as the Key Business Factors section details.
What are the key risks after Syncom Formulations Q2 Results FY27?
Ans. The points to watch after Syncom Formulations Q2 Results FY27 are a higher profit base, an 18.7% margin base and profit growth running ahead of revenue growth, each of which is covered in the risks section.
What is the outlook after Syncom Formulations Q2 Results?
Ans. FY27 full-year results will depend on subsequent quarters, so the outlook after Syncom Formulations Q2 Results rests on future filings, while the Outlook section sets out the figures to follow.
Where can I find the complete Syncom Formulations Q2 Results FY27 data?
Ans. The complete Syncom Formulations Q2 Results FY27 data, including the Financial Highlights table with YoY changes, is on this page, and the Univest app and Screener let readers follow the results date and later quarterly results.
